Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have received an average recommendation of “Hold” from the seven ratings firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $17.3750.
Several analysts recently issued reports on AFYA shares. JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 target price (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. UBS Group reissued a “neutral” rating and set a $16.00 price objective (down previously from $18.00) on shares of Afya in a research report on Friday, January 16th. Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, January 9th. Sanford C. Bernstein upgraded Afya to a “market perform” rating in a research report on Friday, January 16th. Finally, Wall Street Zen lowered Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 31st.
Get Our Latest Analysis on AFYA
Institutional Investors Weigh In On Afya
Afya Trading Down 0.2%
Shares of NASDAQ:AFYA opened at $15.51 on Thursday. The stock’s 50-day simple moving average is $14.81 and its two-hundred day simple moving average is $14.89. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 11.16, a PEG ratio of 0.57 and a beta of 0.50. Afya has a 52-week low of $13.12 and a 52-week high of $19.90. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Articles
- Five stocks we like better than Afya
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
